• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Patient-Reported Outcomes: The Future of Heart Failure Care.

作者信息

Heidenreich Paul A

机构信息

Medical Service, Veterans Affairs Palo Alto Health Care System, Palo Alto, California.

出版信息

JACC Heart Fail. 2019 Oct;7(10):875-877. doi: 10.1016/j.jchf.2019.06.006. Epub 2019 Aug 7.

DOI:10.1016/j.jchf.2019.06.006
PMID:31401093
Abstract
摘要

相似文献

1
Patient-Reported Outcomes: The Future of Heart Failure Care.患者报告结局：心力衰竭护理的未来。
JACC Heart Fail. 2019 Oct;7(10):875-877. doi: 10.1016/j.jchf.2019.06.006. Epub 2019 Aug 7.
2
Patient-reported outcomes for heart failure with preserved ejection fraction: conducting quality studies on quality of life.射血分数保留的心力衰竭患者报告结局：开展关于生活质量的高质量研究。
Eur J Heart Fail. 2020 Jun;22(6):1019-1021. doi: 10.1002/ejhf.1762. Epub 2020 Mar 10.
3
Clinical and Echocardiographic Characteristics and Cardiovascular Outcomes According to Diabetes Status in Patients With Heart Failure and Preserved Ejection Fraction: A Report From the I-Preserve Trial (Irbesartan in Heart Failure With Preserved Ejection Fraction).根据心力衰竭和射血分数保留患者的糖尿病状态的临床和超声心动图特征和心血管结局：来自 I-Preserve 试验（伊贝沙坦治疗射血分数保留心力衰竭）的报告。
Circulation. 2017 Feb 21;135(8):724-735. doi: 10.1161/CIRCULATIONAHA.116.024593. Epub 2017 Jan 4.
4
Patient-reported outcomes in the SOluble guanylate Cyclase stimulatoR in heArT failurE patientS with PRESERVED ejection fraction (SOCRATES-PRESERVED) study.SOCRATES-PRESERVED 研究：射血分数保留的心力衰竭患者中可溶性鸟苷酸环化酶刺激剂的患者报告结局。
Eur J Heart Fail. 2017 Jun;19(6):782-791. doi: 10.1002/ejhf.800.
5
International geographic variation in event rates in trials of heart failure with preserved and reduced ejection fraction.心力衰竭伴射血分数保留和降低的临床试验中事件发生率的国际地域差异。
Circulation. 2015 Jan 6;131(1):43-53. doi: 10.1161/CIRCULATIONAHA.114.012284. Epub 2014 Nov 18.
6
Irbesartan in patients with heart failure and preserved ejection fraction.厄贝沙坦用于射血分数保留的心力衰竭患者。
N Engl J Med. 2008 Dec 4;359(23):2456-67. doi: 10.1056/NEJMoa0805450. Epub 2008 Nov 11.
7
Factors associated with outcome in heart failure with preserved ejection fraction: findings from the Irbesartan in Heart Failure with Preserved Ejection Fraction Study (I-PRESERVE).射血分数保留的心力衰竭结局相关因素：来自 Irbesartan 在射血分数保留的心力衰竭研究（I-PRESERVE）的结果。
Circ Heart Fail. 2011 Jan;4(1):27-35. doi: 10.1161/CIRCHEARTFAILURE.109.932996. Epub 2010 Nov 10.
8
Age-Related Characteristics and Outcomes of Patients With Heart Failure With Preserved Ejection Fraction.年龄相关性特征和射血分数保留的心力衰竭患者的结局。
J Am Coll Cardiol. 2019 Aug 6;74(5):601-612. doi: 10.1016/j.jacc.2019.05.052.
9
Clinical characteristics and outcomes of young and very young adults with heart failure: The CHARM programme (Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity).心力衰竭中青年和极年轻成年人的临床特征和结局：CHARM 计划（坎地沙坦在心力衰竭评估死亡率和发病率降低中的作用）。
J Am Coll Cardiol. 2013 Nov 12;62(20):1845-54. doi: 10.1016/j.jacc.2013.05.072. Epub 2013 Jul 10.
10
Heart failure with mid-range ejection fraction in CHARM: characteristics, outcomes and effect of candesartan across the entire ejection fraction spectrum.CHARM 中射血分数中间值的心衰：特征、结局和坎地沙坦在整个射血分数谱中的作用。
Eur J Heart Fail. 2018 Aug;20(8):1230-1239. doi: 10.1002/ejhf.1149. Epub 2018 Feb 12.

引用本文的文献

1
Value-based health care in heart failure: Quality of life and cost analysis.心力衰竭中的基于价值的医疗保健：生活质量和成本分析。
Clinics (Sao Paulo). 2023 Oct 28;78:100294. doi: 10.1016/j.clinsp.2023.100294. eCollection 2024.
2
Cost-effectiveness of Dapagliflozin for Treatment of Patients With Heart Failure With Reduced Ejection Fraction.达格列净治疗射血分数降低的心力衰竭患者的成本效益分析。
JAMA Cardiol. 2021 Aug 1;6(8):926-935. doi: 10.1001/jamacardio.2021.1437.
3
Patient Perspectives on the Completion and Use of Patient-Reported Outcome Surveys in Routine Clinical Care for Heart Failure.
患者对心力衰竭常规临床护理中患者报告结局调查的完成情况及使用的看法。
Circ Cardiovasc Qual Outcomes. 2020 Sep;13(9):e007027. doi: 10.1161/CIRCOUTCOMES.120.007027. Epub 2020 Aug 31.
4
Opportunities and Challenges of Claims-Based Quality Assessment: The Case of Postdischarge β-Blocker Treatment in Patients With Heart Failure With Reduced Ejection Fraction.基于索赔数据的质量评估的机遇与挑战：以射血分数降低的心力衰竭患者出院后β受体阻滞剂治疗为例
Circ Cardiovasc Qual Outcomes. 2020 Mar;13(3):e006180. doi: 10.1161/CIRCOUTCOMES.119.006180. Epub 2020 Mar 9.